Showing results (11-20 of 244) with videos related to
Sort By:
Pageof 25
Neuro-Oncology|October 15, 2014
Emerging techniques and technologies in brain tumor imagingBenjamin M Ellingson, Martin Bendszus, A Gregory Sorensen, et al.PET Clinics|May 10, 2016
Magnetic Resonance Imaging of Glioma in the Era of Antiangiogenic TherapySarah N Khan, Michael Linetsky, Benjamin M Ellingson, et al.Oncology Reports|May 13, 2015
Patient-specific characterization of the invasiveness and proliferation of low-grade gliomas using serial MR imaging and a mathematical model of tumor growthLeith Hathout, Benjamin M Ellingson, Timothy F Cloughesy, et al.Neuroimage. Clinical|January 25, 2017
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapyNorbert Galldiks, Ian Law, Whitney B Pope, et al.Magnetic Resonance Imaging Clinics of North America|October 16, 2016
Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical PracticeJerrold L Boxerman, Mark S Shiroishi, Benjamin M Ellingson, et al.Current Opinion in Neurology|November 16, 2023
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?Ian Pan, Raymond Y HuangJournal of Neuro-Oncology|March 29, 2011
Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.Journal of Neuro-Oncology|April 7, 2017
Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscapeBenjamin M Ellingson, Caroline Chung, Whitney B Pope, et al.Magnetic Resonance in Medicine|June 25, 2011
Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.Neuro-Oncology|April 26, 2008
Safety of anticoagulation use and bevacizumab in patients with gliomaPhioanh Leia Nghiemphu, Richard M Green, Whitney B Pope, et al.Pageof 25